About Mesalamine 1200 mg (Enteric Coated Prolonged Release Tablet)
Mesalamine 1200 mg Enteric Coated Prolonged Release Tablets are specifically formulated to address gastrointestinal conditions such as ulcerative colitis, ulcerative proctitis, and irritable bowel syndrome (IBS). Each tablet contains 1200 mg of the active ingredient Mesalamine, a proven anti-inflammatory agent that helps reduce swelling in the digestive tract lining and provides sustained relief. The enteric-coated and prolonged-release formulation ensures targeted delivery within the intestines, minimizing irritation to the stomach and optimizing therapeutic efficacy. Manufactured with precision, the tablets are ideal for individuals seeking effective and reliable treatment for chronic gastrointestinal conditions. These tablets are designed for export, ensuring high standards in quality and compliance suitable for global markets.
FAQs of Mesalamine 1200 mg (Enteric Coated Prolonged Release Tablet):
Q: What conditions does Mesalamine 1200 mg treat?
A: This product is recommended for the treatment of ulcerative colitis, ulcerative proctitis, and irritable bowel syndrome (IBS).
Q: How does the enteric-coated prolonged-release formulation work?
A: The formulation ensures targeted delivery of Mesalamine to the intestines, reducing stomach irritation and improving therapeutic effectiveness.
Q: Is this product manufactured for export purposes?
A: Yes, this product is designed for export and adheres to international quality standards suitable for global markets.
Q: How does Mesalamine help with gastrointestinal issues?
A: Mesalamine is an anti-inflammatory agent that reduces swelling in the lining of the digestive tract, providing relief from symptoms associated with gastrointestinal disorders.
Q: What is the dosage of Mesalamine in each tablet?
A: Each tablet contains 1200 mg of Mesalamine.